Table 2 Baseline characteristics among high- and low-dose groups
Variable | High-Dose (n = 14) | Low-Dose (n = 27) | p_Value | ||
|---|---|---|---|---|---|
Age (average ± Std) | 60.46 ± 15.80 | 53.44 ± 15.44 | 0.19 | ||
RACE | 0.447 | ||||
White | 11 (79%) | 23 (85%) | |||
Black | 2 (14%) | 1 (4%) | |||
Hispanic | 1 (7%) | 3 (11%) | |||
Female | 6 (43%) | 19 (70%) | 0.087 | ||
Comorbidity | |||||
Hypertension | 6 (43%) | 5 (19%) | 0.217 | ||
Diabetes Mellitus | 3 (21%) | 1 (4%) | 0.07 | ||
CAD | 2 (14%) | 1 (4%) | 0.217 | ||
CKD | 2 (14%) | 2 (7%) | 0.482 | ||
Cancer Type | < 0.001 | ||||
Breast | 0 (0%) | 19 (70%) | |||
Lymphoma | 12 (86%) | 2 (7%) | |||
Others | 2 (14%) | 6 (22%) | |||